FEDERATED HERMES, INC. - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$262,000
+26100.0%
77,403
+184192.9%
0.00%
Q3 2021$1,000
-50.0%
42
-92.0%
0.00%
Q2 2021$2,000
-50.0%
523
-36.9%
0.00%
Q1 2021$4,000
+100.0%
829
+155.1%
0.00%
Q4 2020$2,000
-33.3%
325
-6.9%
0.00%
Q3 2020$3,000
+50.0%
349
-32.5%
0.00%
Q2 2020$2,000
-98.9%
517
-99.6%
0.00%
-100.0%
Q1 2020$185,000
-4.1%
125,039
+26.8%
0.00%
Q4 2019$193,000
+3.8%
98,588
+170.8%
0.00%
Q3 2019$186,000
+675.0%
36,403
+998.1%
0.00%
Q2 2019$24,000
+300.0%
3,315
+667.4%
0.00%
Q1 2019$6,000
+200.0%
432
+151.2%
0.00%
Q1 2018$2,000
-85.7%
172
-92.8%
0.00%
Q2 2017$14,000
+55.6%
2,393
+12.8%
0.00%
Q1 2017$9,0002,1210.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders